Dr Stramezzi talks about his experience, his perspectives on treatment of Covid-19, his telemedicine service & the upcoming International Covid Summit in Rome in September.
On October 8, 2019, the French Minister of Health began the process of putting HCQ on a list of poisonous substances after it was available OTC for decades without a problem. She is married to the former CEO of INSERM, which arranged the building of the first level 4 biosafety lab in mainland China, known as the Wuhan Institute of Virology. The pressure was building to bury the news of medical agents that successfully treat COVID-19 infection from a very early moment. We needed to organize early to stop that genocide.
Source: Francesoir Italy has been talked about a lot since the start of the Covid crisis in 2020 with first of all a significant mortality
HCQ is effective for COVID-19. The probability that an ineffective treatment generated results as positive as the 235 studies to date is estimated to be 1 in 6 quadrillion (p = 0.00000000000000018).
Early treatment is most successful, with 100% of 29 studies reporting a positive effect (13 statistically significant in isolation) and an estimated reduction of 65% in the effect measured (death, hospitalization, etc.) using a random effects meta-analysis, RR 0.35 [0.25-0.50].
92% of Randomized Controlled Trials (RCTs) for early, PrEP, or PEP treatment report positive effects, the probability of this happening for an ineffective treatment is 0.0017.
It would be a historically amazing feat of maneuvering bureaucracy, worthy of its own epic book, movie, or perhaps a campfire song, to have wrangled that much data out of those hospitals with highly variable regulations and procedures, nearly all of which are in the U.S. healthcare system.
From an ingenious intuition of the founder, Mauro Rango, an Italian living in the Mauritius Islands. There, the Coronavirus was quickly eradicated in the beginning, with drugs that we have known for decades, such as Azithromycin, Hydroxychloroquine or Cortisone, while in Italy people died like flies. How was it possible that in Africa, where health care is not as advanced as in Italy, such marvellous results were achieved, while in Italy the spread of the disease could not be contained?
Santin’s endorsement is not only important but broad. He said he has seen ivermectin work at every stage of COVID — preventing it, eliminating early infection, quelling the destructive cytokine storm in late infection, and helping about a dozen patients so far who suffered months after COVID.
The new Regional Minister for Health, Luigi Genesio Icardi : “We introduce the use of hydroxychloroquine in the early stage of the disease, along with nonsteroidal anti-inflammatory drugs and vitamin D
None of the 788 who took 12mg of ivermectin weekly became ill with Covid vs 58% out of 407 control subjects
From my patients who are treated by me from the beginning, I have had no deaths.
This report forms the scientific basis for the decision to authorise hydroxychloroquine in the treatment of Covid-19 in the early phase of the disease.
We will introduce, within our ‘Covid at home’ protocol, the use of hydroxychloroquine; it can be used by doctors according to science and conscience.
The evidence provided by AIFA was not enough to limit the individual doctors’ decisional autonomy; the ban on hydroxychloroquine was reversed on 11 December.
Source: ANSA The III Section of the Council of State accepted, as a precautionary measure, the appeal of a group of general practitioners and suspended
Source: RMC101 Media Group A cure that works, which has saved many lives, but which is not recognized by official protocols. It’s battle over hydroxychloroquine. A difficult
Source: Affaritaliani Author: Monica Camozzi Interview with Andrea Stramezzi, one of the many doctors who silently treats – and heals – many coronavirus patients –
Source: HCQMeta.com HCQ is effective for COVID-19 when used early: meta-analysis of 156 studies (Version 28, December 4, 2020) • HCQ is effective for COVID-19.
Source: Research Square. Augusto Di Castelnuovo, Mediterranea Cardiocentro, NapoliSimona Costanzo, Department of Epidemiology and Prevention, IRCCS Neuromed, PozzilliAntonio Cassone, Polo della genomica, genetica e biologia,
Results obtained in the prophylaxis of Q fever indicate that chloroquine/hydroxychloroquine can be successfully used in the clinical management of infections other than malaria.
Source: PiaCenza24 Author: FPG Home anti-Covid therapy with Hcl: solution to lockdown found. Solution already active in Piedmont. And from the scientific community comes an appeal to
Figure 3 reported random forest for 10 studies comparing HCQ+AZM. Use of the combination HCQ+AZM was associated with 25% lower mortality risk
Source: HCQmeta.com • HCQ is effective for COVID-19. The probability that an ineffective treatment generated results as positive as the 132 studies to date is
Source: Clinical & Translational Science Marinella Lauriola Arianna Pani Giovanbattista IppolitiAndrea MortaraStefano MilighettiMarjieh MazenGianluca PerseghinDaniele PastoriPaolo GrossoFrancesco Scaglione doi:10.1111/cts.12860 Full study here. Abstract Conflicting evidence
Source: The Gateway Pundit Author: Eric A. Blair An Italian study finds that hydroxychloroquine substantially reduces the risk of death for COVID-19 patients. “We observed
Asian countries overall have fared better in controlling Covid-19, with lower mortality which is due to demographics and use of HCQ.
Hydroxychloroquine may interfere with viral infection or cytokine storms observed in Covid-19 with severe acute respiratory distress syndrome.
Our study, including a large sample of patients hospitalized with COVID-19 in Italy, shows HCQ use had a 30% reduction of overall in-hospital mortality.
HCQ use was associated with a 30% lower risk of death in COVID-19 hospitalized patients. Our data doesn’t discourage use of HCQ in inpatients with COVID-19.
This Multicenter Study shows that the risk of death is 30% lower for coronavirus patients treated with hydroxychloroquine.
Source: France Soir An Italian study carried out on a group of more than 3,000 patients, hospitalized for Covid-19, concluded that “the use of hydroxycholoroquine
Source: Newsmax An Italian study found that hospitalized coronavirus patients who took anti-malaria drug hydroxychloroquine combined with azithromycin were 66% less likely to die. Science Direct reports that
hydroxycholoroquine + azithromycin was associated with a 66% reduction in risk of death as compared to controls; the analysis also suggested a larger effectiveness of hydroxychloroquine in patients with less severe COVID-19 disease
Of the patients I treated, only 5% needed to be hospitalized. Nobody died.
Source: Global Research A few years ago the British medical journal, The Lancet, published a paper touting the safety of HCQ. But this was before HCQ
Source: The Jerusalem Post Annalisa Chiusolo shows how the drug hydroxychloroquine could make people immune to virus COVID-19 damages the hemoglobin, impairing the ability of
Source: ilfattoquotidiano“I am a doctor and, positive for Covid19 , I immediately took hydroxychloroquine : in 3-4 days the fever and the other symptoms disappeared “. This is how Paola Varese , head of cancer medicine at the Ovada hospital in Piedmont , begins. “I
Starting today, in fact (availability permitting), all patients treated at home for contracting Covid-19 will be able to withdraw hydroxychloroquine-based drugs (plaquenil cpr 200 or
Source: iltempoInterview with the Italian researcher Andrea Savarino reveals research on 211 people, showing how prophylaxis with hydroxychloroquine prevents the infection of Covid-19. The result
Hydroxychloroquine (HCQ) appears as an additional therapy, as it possesses immunomodulatory and anti-thrombotic various effects [4-16].
Chloroquine and hydroxychloroquine, with an original indication to prevent or cure malaria, have been successfully used to treat several infectious diseases.
